Marlborough, Mass., April 20, 2026--Research presented at the Society of Breast Imaging SBI Symposium backs Hologic AI-powered mammography technology for detecting challenging cancers.
Hologic Inc (HOLX) โ Live Session & Technical Brief
Updated Nov 22, 2026 7:10 AM ET ยท Prev Close $75.65
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (+0.48%) in Medical Instruments & Supplies
Hologic Inc (HOLX) is trading within a tight intraday band at $76.01 (+0.48%, 12.36x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, HOLX is outperforming the S&P 500 by +4.12%. 14-day RSI stands at 69.0, keeping momentum in a bullish regime.
Marlborough, Mass., April 20, 2026--Research presented at the Society of Breast Imaging SBI Symposium backs Hologic AI-powered mammography technology for detecting challenging cancers.
Price ($76.01) holds above both 20-day ($75.47) and 50-day ($75.29) moving averages.
Market & Sector Relative Strength
HOLX outperforming the S&P 500 by +4.12%Recent HOLX Catalyst Headlines
Verified WireThe company appointed Almeida as chief executive in conjunction with the completion of an 18.3 billion go-private deal.
Marlborough, Mass. New York San Francisco Fort Worth, Texas, April 07, 2026--Blackstone and TPG Complete Acquisition of Hologic Accomplished MedTech leader Joe Almeida named Chief Executive Officer
TPG Inc. Nasdaq Tpg is included among the 14 Value Stocks with Highest Dividends. On April 9, TD Cowen analyst Bill Katz lowered the firm s price recommendation on TPG Inc. Nasdaq Tpg to 41 from 49. It reiterated a Hold
1โ3 Day Expected Range & Key Level
54% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $75.47 (20-day SMA support) for directional breakout confirmation.
Technical Regime (HOLX)
BULLISH MA TRENDRetail & Crowd Sentiment
NeutralHologic CEO Steve MacMillan to retire upon completion of go-private transaction with Blackstone and TPG.
About Hologic Inc
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest โฆ
Get Instant HOLX Catalyst Alerts
Receive an email alert when HOLX triggers an unusual volume breakout, options sweep, or rating shift.
HOLX Session & Catalyst FAQ
Why is HOLX stock trading near flat today?
Hologic Inc (HOLX) is trading within a tight intraday band at $76.01 (+0.48%, 12.36x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, HOLX is outperforming the S&P 500 by +4.12%. 14-day RSI stands at 69.0, keeping momentum in a bullish regime.
Is HOLX stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 12.36x relative volume (high participation). Our multi-factor model currently rates HOLX as BUY. Review full valuation, quality, and timing signals on the HOLX Buy or Sell Decision Brief โ
What is HOLX's intrinsic value and expected trading range?
At $76.01, HOLX's modeled 1-to-3 session range is $74.15 โ $77.87, with a key inflection level at $75.47 (20-day SMA support). Compare current price against multi-year cash flow projections in the HOLX Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for HOLX?
RSI at 69.0 reflects constructive bullish momentum. HOLX trades at $76.01 relative to its 20-day SMA ($75.47) and 50-day SMA ($75.29), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.